OTCM
BRSF
Market cap0kUSD
May 13, Last price
0.00USD
Name
Brain Scientific Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Brain Scientific Inc., a medical technology enterprise established in 2013 and based in Sarasota, Florida, delivers neurology-focused medical devices and electric motors across the United States. The company further engages in the development of sophisticated motor platforms, an exceptionally precise micro-dosing pump, and various motion control products. Among its key offerings is NeuroCap, an inventive disposable, soft-layered cap featuring an integrated electrode circuit, specifically engineered to overcome the common challenges of conventional EEG systems. Brain Scientific also provides NeuroEEG, a clinical-grade device available by prescription, designed for capturing, recording, transmitting, and visualizing electrical brain activity in individuals of all ages. Supporting these devices is NeuroNet Cloud, a dedicated database for securely storing and analyzing brain-related data.
Legal address
101 North Carson Street
Suite 3
Carson City, NV 89701
US
Suite 3
Carson City, NV 89701
US
Headquarters
3904 West 3930 South
Salt Lake City, UT 84120
US
Salt Lake City, UT 84120
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||